logo
Select company
Select metric
$ -2.54MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
39
Sector
44
Industry
47
History
61
$ 0.79Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information

Ticker

CUE

Company Name

CUE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CUE BIOPHARMA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CUE - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -2.54M
3/31/2025$ -27.89M
12/31/2024$ -26.05M
9/30/2024$ -22.27M
6/30/2024$ -22.87M
3/31/2024$ -15.14M
12/31/2023$ -3.1M
9/30/2023$ 24.97M
6/30/2023$ -13.22M
3/31/2023$ -11.76M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CUE BIOPHARMA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 40.35M.
  • Over the past 5 years, CUE BIOPHARMA INC's average CF - Chg. Cash has been $ -3.17M.
  • The median CF - Chg. Cash for CUE BIOPHARMA INC during this period was $ -9.14M
  • CUE BIOPHARMA INC reached its highest CF - Chg. Cash over the past 5 years at $ 49.83M.
  • The lowest CF - Chg. Cash recorded by CUE BIOPHARMA INC in the same timeframe $ -37.91M

CUE BIOPHARMA INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
OVID : OVID THERAPEUTICS INC $ -1.28MVERU : VERU INC $ -14.14MPSTV : PLUS THERAPEUTICS INC $ -2.68MCRVO : CERVOMED INC $ -1.69MSRZN : SURROZEN INC $ 52.63MTCRX : TSCAN THERAPEUTICS INC $ -72.77MCBUS : CIBUS INC $ 6.44MFATE : FATE THERAPEUTICS INC $ -618KALGS : ALIGOS THERAPEUTICS INC $ -26.38MPYXS : PYXIS ONCOLOGY INC $ -14.34M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

CUE - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -37.91M

Minimum

Sep 30, 2022

$ 49.83M

Maximum

Mar 31, 2021

$ -3.17M

Average

$ -9.14M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M